This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Interactive Response Technology

Streamline Your IRT Across the Clinical Supply Chain

Regulatory Requirements. Insourcing vs. Outsourcing. Clinical Collaboration.

Hear from leaders in the field

Gain strategic insights for successful management of patient randomization and drug supply chains.

Deep Dive into Case Studies:
  • Amgen's innovative supplier selection process  
  • Biogen and Pfizer share insights into an outsourced approach and an in-sourced approach for IRT systems
  • GSK guide you on effectively leveraging your IRT to ensure seamless data integration throughout your organization
Strategies and Considerations for Direct-to-Patient Trials:
  • How will IRT be impacted from Direct-to-Patient and virtual trials?
  • Attend a fireside chat on trial burden from the site and patient perspective
  • COVID-19 pandemic response: Challenges in the virtual space and solutions to overcome them



Panel Discussions Covering:
  • A point-counterpoint – the value of data and IRT
  • Best practices and lessons learned for IRT inspection readiness
  • Design thinking for IRT – if sponsor customizations weren’t requested, what would vendors build?

Is Your Interactive Response Technology Evolving with the Supply Chain?

As IRT continues to evolve for clinical trials, discover the latest updates in the industry and how to stay ahead of the competition.

Review multiple case studies and join a debate on the pros and cons of using an Outsourced versus In-Sourced Approach to IRT

Learn more about Direct-to-Patient and Virtual Trials and how IRT will be impacted

Hear an Innovative Supplier Selection Process Case Study form Amgen

Join a Panel discussion on Design Thinking for IRT from the Vendor Perspective
(What innovations would they build if Sponsors customizations weren’t requested?)

IRT: 2019 Attendees

  • 3i Group
  • 4G Clinical
  • AbbVie
  • Almac Clinical Technologies
  • Alnylam Pharmaceuticals Inc
  • Amgen
  • Apellis Pharmaceuticals
  • Astellas Pharmaceuticals
  • Axiom Real Time Metrics
  • Bayer
  • BeiGene
  • Bellerophon Therapeutics
  • Berlinger & Co AG
  • BioClinica
  • Biogen
  • BioMarin
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Celgene
  • Cenduit
  • Clinical Technology Consultants Ltd
  • Cognizant Technology Solutions
  • CSL Behring
  • Eli Lilly & Co
  • Endpoint
  • endpoint Clinical
  • engagedIN
  • Exelixis
  • Fate Therapeutics
  • Ferring Pharmaceutical AS
  • Gilead Sciences Inc
  • GlaxoSmithKline
  • ICON Clinical Research
  • Janssen
  • Kyowa Kirin
  • McCreadie Group Inc
  • Medidata Solutions
  • Merck
  • Oracle
  • PAREXEL International
  • PCI Pharma Services
  • Pfizer Inc
  • Pharmaceutical Commerce
  • Poxy Clinical IRT UAT Services
  • PPD
  • Prevail Infoworks
  • Regeneron Pharmaceuticals
  • Rho
  • S Clinica
  • Seattle Genetics
  • Seattle Genetics Inc
  • Signant Health
  • Statistics & Data Corp
  • Suvoda
  • Taiho Oncology
  • Takeda
  • Theravance Biopharma
  • Ultragenyx Pharmaceutical
  • Veracity Logic LLC
  • Vertex Pharmaceuticals
  • YPrime